Inhibition of NLRP3 inflammasome activation has also been proven to be effective in inhibiting the inflammatory responses of monocytes and in ameliorating joint inflammation in RA patients in a collagen-induced arthritis model [24]. Here, NLRP3 is linked to rheumatoid arthritis.